Back
Verrica Pharmaceuticals Vs. Strategy Industry Stock Comparison
Sell
20
VRCA
Verrica Pharmaceuticals
Last Price:
$0.49
Seasonality Move:
-11.93%
Buy
52
MSTR
Strategy
Last Price:
$317.29
Seasonality Move:
4.22%
Sell
20
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
-
The current Verrica Pharmaceuticals [VRCA] share price is $0.49. The Score for VRCA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
VRCA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.49The current trend is relatively stagnant and VRCA is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 46.67 | Sell |
Chaikin Money Flow: | 374599 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.43 - 0.59) | Sell |
Bollinger Bands (100): | (0.51 - 0.89) | Sell |
MSTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.39 | Buy |
Relative Strength Index (14 RSI): | 54.43 | Buy |
Chaikin Money Flow: | 8106657 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (278.73 - 322.47) | Buy |
Bollinger Bands (100): | (286.79 - 379.05) | Sell |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.5 | Sell |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.59 | Sell |
200-day SMA: | 2.08 | Sell |
8-day EMA: | 0.5 | Sell |
20-day EMA: | 0.51 | Sell |
50-day EMA: | 0.59 | Sell |
200-day EMA: | 1.93 | Sell |
MSTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 294.77 | Buy |
20-day SMA: | 301.69 | Buy |
50-day SMA: | 299.89 | Buy |
200-day SMA: | 254.47 | Buy |
8-day EMA: | 303.26 | Buy |
20-day EMA: | 298.72 | Buy |
50-day EMA: | 303.39 | Buy |
200-day EMA: | 262.34 | Buy |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.12 per share.
Strategy Earnings Growth & MSTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $38.16 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.
Verrica Pharmaceuticals Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Strategy Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |